Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women

Journal of Applied Physiology

Volumn 90, Issue 6, 2001, Pages 2033-2040

  Evans, Ellen M ^a   Van Pelt, Rachael E ^b   Binder, Ellen F ^a   Williams, Daniel B ^a   Ehsani, Ali A ^a   Kohrt, Wendy M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Abdominal obesity; Estrogens; Hormone replacement therapy; Insulin resistance

Indexed keywords

CONJUGATED ESTROGEN; GLUCOSE; INSULIN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0034996725     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.90.6.2033     Document Type: Article

References (45)

1. Aloia JF, McGowan DM, Vaswani AN, Ross P, and Cohn SH. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 53: 1378-1383, 1991.
2. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, and Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82: 638-643, 1997.
3. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 20: 291-302, 1997.
4. Brown M, Birge SJ Jr, and Kohrt WM. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol Biol Sci Med Sci 52A: B166-B170, 1997.
5. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, and Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40: 843-849, 1997.
6. Crook D, Godsland IF, Hull J, and Stevenson JC. Hormone replacement therapy with dydrogesterone and 17β-oestadial: effects on serum lipoproteins and glucose tolerance during 24 mo follow up. Br J Obstet Gynaecol 104: 298-304, 1997.
7. Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, and Lanzone A. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140: 215-223, 1999.
8. Deprés JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res 6: 8S-17S, 1998.
9. Deprés JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Theriault G, and Bouchard C. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol Endocrinol Metab 261: E159-E167, 1991.
10. Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JM, and Lumsden MA. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 84: 2402-2407, 1999.
11. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, and Greenfield M. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 82: 1549-1556, 1997.
12. Ettinger B, Selby J, Citron JT, Vangessel A, Ettinger VM, and Hendrickson MR. Cyclic hormone replacement therapy using quarterly progestin. Obstet Gynecol 83: 693-700, 1994.
13. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, and Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82: 414-417, 1997.
14. Holloszy JO and Hansen PA. Regulation of glucose transport into skeletal muscle. In: Reviews of Physiology, Biochemistry and Pharmacology, edited by Blaustein MP, Grunicke H, Habermann E, Pette D, Schultz G, and Schweiger M. Berlin: Springer-Verlag, 1996, p. 99-193.
15. Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, and Berger M. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 6: 36-42, 1999.
16. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, and Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-yr-old men and women. J Gerontol 48: M84-M90, 1993.
17. Kohrt WM, Ehsani AA, and Birge SJ. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J Appl Physiol 84: 1506-1512, 1998.
18. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, and Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes 42: 273-281, 1993.
19. O2 max to training in 60-71 yr olds. J Appl Physiol 71: 2004-2011, 1991.
20. Kohrt WM, Malley MT, Dalsky GP, and Holloszy JO. Body composition of healthy sedentary and trained, young and older men and women. Med Sci Sports Exerc 24: 832-837, 1992.
21. Kohrt WM, Obert KA, and Holloszy JO. Exercise training improves fat distribution patterns in 60- to 70-yr-old men and women. J Gerontol 47: M99-M105, 1992.
22. Kohrt WM, Snead DB, Slatopolsky E, and Birge SJ Jr. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J Bone Miner Res 10: 1303-1311, 1995.
23. Lamarche B, Deprés JP, Pouliot MC, Moorjani S, Lupien PJ, Theriault G, Tremblay A, Nadeau A, and Bouchard C. Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following aerobic exercise training in obese women? Metabolism 41: 1249-1256, 1992.
24. Levine R and Haft D. Carbohydrate homeostasis. N Engl J Med 283: 237-246, 1970.
25. Lobo RA, Pickar JH, Wild RA, Walsh B, and Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopausal Study Group. Obstet Gynecol 84: 987-995, 1994.
26. Matsuda M and DeFronzo RA. Insulin sensitivity indices obtained from oral gluocse tolerance testing. Diabetes Care 22: 1462-1470, 1999.
27. Mendoza S, Velazquez E, Osona A, Hamer T, and Glueck CJ. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein(a). J Lab Clin Med 123: 837-841, 1994.
28. Morgan DR and Lazarow A. Immunoassay of insulin: two antibody system. Diabetes 12: 115-126, 1963.
29. Nelson ME, Fisher EC, Dilmanian FA, Dallal GE, and Evans WJ. A 1-yr walking program and increased dietary calcium in postmenopausal women: effects on bone. Am J Clin Nutr 53: 1304-1311, 1991.
30. Poehlman ET, Toth MJ, and Gardner AW. Changes in en ergy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123: 673-675, 1995.
31. Ross R, Dagnone D, Jones PJH, Smith H, Paddags A, Hudson R, and Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med 133: 92-103, 2000.
32. Saartok T. Steroid receptors in two types of rabbit skeletal muscle. Int J Sports Med 5: 130-136, 1984.
33. Samaras K, Hayward CS, Sullivan D, Kelly RP, and Campbell LV. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care 22: 1401-1407, 1999.
34. Sauerwein H and Meyer HH. Androgen and estrogen receptors in bovine skeletal muscle: relation to steroid-induced allometric muscle growth. J Anim Sci 67: 206-212, 1989.
35. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, and Holloszy JO. Glucose tolerance in young and older athletes and sedentary men. J Appl Phvsiol 56: 1521-1525, 1984.
36. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead MI, and Stevenson JC. Effects of oral and transdermal 17β-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism 49: 742-747, 2000.
37. Stachenfeld NS, DiPietro L, Palter SF, and Nadel ER. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol Regulatory Integrative Comp Physiol 274: R187-R195, 1998.
38. Tchernof A and Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6: 246-254, 1998.
39. Tchernof A, Poehlman ET, and Deprés JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 26: 12-20, 2000.
40. Toth MJ and Poehlman ET. Effects of exercise on daily energy expenditure. Nutr Rev 54: S140-8, 1996.
41. Toth MJ, Tchernof A, Sites CK, and Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 24: 226-231, 2000.
42. Trenkle A. The anabolic effect of estrogens on nitrogen metabolism of growing and finishing cattle and sheep. In: Anabolic Agents in Animal Production, edited by Lu FC and Rendel J. Stuttgart, Germany: Thieme, 1976, p. 79-88.
43. Van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Droop A, and Bakker CJ. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr 57: 327-333, 1993.
44. Van Pelt RE, Davy KP, Stevenson ET, Wilson TM, Jones PP, DeSouza CA, and Seals DR. Smaller differences in total and regional adiposity with age in women who regularly perform endurance exercise. Am J Physiol Endocrinol Metab 275: E626-E634, 1998.
45. Williams DB, Voigt BJ, Fu YS, Schoenfeld MJ, and Judd HL. Assessment of less than monthly progestin therapy in post-menopausal women given estrogen replacement. Obstet Gynecol 84: 787-793, 1994.